Please use this form to send any questions, bug reports, or suggestions. If you are reporting a bug, please include detailed information about what you were doing, and attach any relevant screenshots, if possible.
Thank you for providing your feedback! Someone will be in touch with you shortly. This window will automatically close in 5 seconds.
A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. [PubChem]
Aminosyn 10% W Electrolytes
Aminosyn 3.5% M
Aminosyn 8.5% Injection With Electrolytes
Aminosyn II 10%
Aminosyn II 10% With Electrolytes
Aminosyn II 15%
Aminosyn II 5% Inj
Aminosyn II 7% Injection
Aminosyn II 8.5% Injection
Aminosyn II With Electrolytes
Aminosyn Sulfite Free
Antacid 2 Tablets
Glycine 1.5% Irrigation
Glycine 1.5% Irrigation USP Sol
Glycine Irrigation 1.5% USP
Ph 12 Sterile Diluent for Flolan
Premasol - Sulfite-free (amino Acid)
Primene 10%-liq IV
Renamin (amino Acids) Injection
Sterile Diluent for Flolan Injection
Travasol Amino Acid Inj 5.5%
Travasol Amino Acid Inj 8.5%
Travasol Inj Without Electrolytes 5.5%
Vamin 18 Electrolyte-free
Humans and other mammals
Supplemental glycine may have antispastic activity. Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti-inflammatory activities.
Helps trigger the release of oxygen to the energy requiring cell-making process; Important in the manufacturing of hormones responsible for a strong immune system.
Mechanism of action
In the CNS, there exist strychnine-sensitive glycine binding sites as well as strychnine-insensitive glycine binding sites. The strychnine-insensitive glycine-binding site is located on the NMDA receptor complex. The strychnine-sensitive glycine receptor complex is comprised of a chloride channel and is a member of the ligand-gated ion channel superfamily. The putative antispastic activity of supplemental glycine could be mediated by glycine's binding to strychnine-sensitive binding sites in the spinal cord. This would result in increased chloride conductance and consequent enhancement of inhibitory neurotransmission. The ability of glycine to potentiate NMDA receptor-mediated neurotransmission raised the possibility of its use in the management of neuroleptic-resistant negative symptoms in schizophrenia. <br/>Animal studies indicate that supplemental glycine protects against endotoxin-induced lethality, hypoxia-reperfusion injury after liver transplantation, and D-galactosamine-mediated liver injury. Neutrophils are thought to participate in these pathologic processes via invasion of tissue and releasing such reactive oxygen species as superoxide. In vitro studies have shown that neutrophils contain a glycine-gated chloride channel that can attenuate increases in intracellular calcium and diminsh neutrophil oxidant production. This research is ealy-stage, but suggests that supplementary glycine may turn out to be useful in processes where neutrophil infiltration contributes to toxicity, such as ARDS.
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682